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Abstract
Background Major brain injury and uncontrolled blood loss remain the primary causes of early trauma-related mortality. 
One-quarter to one-third of trauma patients exhibit trauma-induced coagulopathy (TIC). Thromboelastometry (ROTEM) 
and thrombelastography (TEG) are valuable alternatives to standard coagulation testing, providing a more comprehensive 
overview of the coagulation process.
Purpose Evaluating thromboelastographic profile, the incidence of fibrinolysis (defined as Ly30 > 3%) in severe trauma 
patients, and factors influencing pathological coagulation pattern.
Methods Prospective observational 2 years cohort study on severe trauma patients assisted by Helicopter Emergency Medi-
cal System (HEMS) and Level 1 Trauma Center, in a tertiary referral University Hospital.
Results Eighty three patients were enrolled, mean NISS (new injury severity score) 36 (± 13). Mean R value decreased from 7.25 
(± 2.6) to 6.19 (± 2.5) min (p < 0.03); 48 (60%) patients had a reduction in R from T0 to T1. In NISS 25–40 and NISS > 40 groups, 
changes in R value increased their significance (p = 0.04 and p < 0.03, respectively). Pathological TEG was found in 71 (88.8%) patients 
at T0 and 74 (92.5%) at T1. Hypercoagulation was present in 57 (71.3%) patients at T0, and in 66(82.5%) at T1. 9 (11.3%) patients 
had hyperfibrinolysis at T0, 7 (8.8%) patients at T1. Prevalence of  StO2 < 75% at T0 was greater in patients whose TEG worsened (7 
patients, 46.7%) against whose TEG remained stable or improved (8 patients, 17.4%) from T0 to T1 (p = 0.02). 48 (57.8%) patients 
received < 1000 mL of fluids, while 35 (42.2%) received ≥ 1000 mL. The first group had fewer patients with hypercoagulation (20, 
41.6%) than the second (6, 17.6%) at T1 (p < 0.03). No differences were found for same TEG pattern at T0, nor other TEG pattern.
Conclusion Our population is representative of a non-hemorrhagic severe injury subgroup. Almost all of our trauma popula-
tion had coagulation abnormalities immediately after the trauma; pro-coagulant changes were the most represented regard-
less of the severity of injury. NISS appears to affect only R parameter on TEG. Hyperfibrinolysis has been found in a low 
percentage of patients. Hypoperfusion parameters do not help to identify patients with ongoing coagulation impairment. 
Small volume resuscitation and mild hypotermia does not affect coagulation, at least in the early post-traumatic phase.
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Introduction
Major brain injury and uncontrolled blood loss remain the 
primary causes of early trauma-related mortality [1–3]. 
One-quarter to one-third of trauma patients exhibit trauma-
induced coagulopathy (TIC) [4, 5], which is associated with 
increased rates of massive transfusion (MT) and multiple 
organ failure (MOF), prolonged intensive care unit (ICU) 
and hospital length-of-stay, and a four-fold increase in mor-
tality [4]. Most patients with coagulopathy have uncontrolled 
bleeding as well, and early diagnosis of the underlying coag-
ulation disorder is paramount for effective treatment.
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The pathogenesis of severe post-traumatic coagulopathy 
is complex and multifactorial. It involves factor-related pri-
mary to the trauma itself and, later, to medical treatment 
provided [6, 7]. Coagulopathy secondary to the extravasa-
tion of tissue factor and hypoperfusion is associated with 
a poor outcome such as MOF and death [8]. TIC—which 
differs from disseminated intravascular coagulation—is a 
result of enhanced activity of plasma coagulation during the 
initial phase. TIC is characterized by early-onset prolonged 
prothrombin time and activated partial thromboplastin time 
and a relative sparing of platelets and fibrinogen [9].
Viscoelastic hemostatic assays (VHA)—such as throm-
boelastometry (ROTEM) and thromboelastography (TEG)—
are valuable alternatives to standard coagulation testing, pro-
viding a more comprehensive overview of the coagulation 
process [10, 11]. In contrast to most standard coagulation 
measurements, TEG can be used as a point-of-care method. 
VHAs permit goal-directed therapy for TIC [12].
Different studies have described an early post-traumatic 
coagulopathy in 24–36% of trauma patients upon admis-
sion to the emergency department [5, 13]. This early coagu-
lopathy was a marker of injury severity and was related to 
mortality. More recently, TIC was found in a percentage 
from 8 to 14% of trauma patients, but a very different mode 
to diagnose it was highlighted [14–16]. Furthermore, up to 
date, there are only two prospective studies evaluating the 
initial coagulation status with VHA [17] and with VHA plus 
traditional analysis [15], on pre-hospital setting and at hospi-
tal admission, respectively. The hypothesis was that coagula-
tion abnormalities became apparent very early, already on 
the accident site.
The purpose of this prospective observational cohort 
study is to describe the on-scene and on-hospital-arrival 
coagulation profile with a point-of-care TEG to detect early 
coagulation modification and fibrinolysis (Lys30 > 3%) in 
severe trauma patients.
Materials and methods
Our hospital research ethics committee approved this sin-
gle-center, prospective, observational study (codice CE). 
Because most of these patients would be unconscious, and 
the next of kin was not readily available, the requirement for 
informed consent, under the provisions of the ethics com-
mittee and because the observational nature of the study, 
was waived.
We enrolled in any severe trauma adult (> 18 years) 
patient rescued by our HEMS crew from December 2014 
to December 2016. Severe trauma was defined as a new 
injury severity score (NISS) of more than 15. We excluded 
patients undergoing anticoagulant therapy before the 
trauma.
A blood count sample, a blood sample in citrate (for 
TEG and coagulation tests), and arterial blood gas (ABG) 
analysis were collected for each patient on the trauma 
scene (T0) and at hospital arrival (T1). T0 and T1 refers 
to time interval between activation of the emergency 
response system and, respectively, the arrival on trauma 
scene or hospital admission.
For each patient, we registered: demographic character-
istics, type of trauma, trauma dynamic, vital parameters 
(non-invasive blood pressure (NIBP), heart rate (HR), 
respiratory rate (RR), oxygen saturation  (SpO2), tissue 
oxygen saturation  (StO2; InSpectra Model 325; Hutchin-
son Thecnology Inc., Hutchinson, MN, USA), temperature 
(°C) at T0 and T1, tranexamic acid and fluid administration, 
blood components transfused in first 24 h, NISS.
For TEG analysis, a Computerized Thromboelastograph 
Coagulation  Analyzer® (TEG model 5000, Haemoscope 
Corporation, Niles, IL, USA) was used. The instrument 
had quality control performed daily, and the tests per-
formed were following manufacturer specifications. All 
analyses were performed by staff trained in their use with 
regular assessments on their ability to perform the tests. 
340 µL of blood added with 20 µL of  CaCl2 (0.2 M) was 
pipetted into a TEG cup pre-warmed to 37 °C. The follow-
ing TEG variables were assessed: R time (reaction time; s), 
K (kinetics; s), angle (alpha angle, which means the slope 
of line between R and K; grades), MA (maximum ampli-
tude; mm), G (a log-derivation of the MA, representing 
clot strenght; dyne/s), LY30 (lysis at 30 min, which means 
percentage decrease in amplitude at 30 min post-MA; %).
We collected Hematocrit (Htc, %), Hemoglobin (Hb, 
g  dL−1), Platelet (PLT, n° × 103 μL−1) (Beckman Coulter 
 Unicel®DxH 800  Coulter®, Miami, FL, USA) from blood 
count sample and Base Excess (BE in mmol  L−1) from 
ABG. Coagulation laboratory tests Prothrombin Time 
(PT) (Recombiplastin  2G®, Instrumentation Laboratory 
Co, Orangeburg, USA), International Normalized Ratio 
(INR), Partial Thromboplastin Time (PTT) (APTT-SP®, 
Instrumentation Laboratory Co, Orangeburg, USA) and 
fibrinogen (FBN) (Q.F.A.®, ACL TOP 700, Instrumen-
tation Laboratory Co, Orangeburg, USA) were obtained. 
Trauma-induced coagulopathy (TIC) was defined as 
INR > 1.5 [18]. Pathological TEG was defined as a TEG 
in which at least one parameter (between R time, MA and 
G) was out of normality range. Normality range: R time 
9–27 s, MA 44–64 mm, G 3.6–8.5 dyne/s. Hypocoagu-
lation was defined as at least 2 of these criteria: R > 27, 
MA < 44 or G < 3.6. Hypercoagulation was defined as at 
least two of these criteria: R < 9, MA > 64 or G > 8.5.
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Statistical analysis
Data are presented as the number of patients and percent-
age or as mean ± standard deviation and range (minimum 
and maximum). The groups were compared with the 
Mann–Whitney test. A p value ≤ 0.05 was considered sta-
tistically significant. All statistical analyses were performed 
using the R-CRAN project ver. 3.5.2.
Results
We enrolled 94 trauma patients rescued by HEMS. Eleven 
patients were excluded: six because of non-traumatic emer-
gencies, four because they presented a NISS < 15, and one 
patient for the absence of TEG data. We finally included 
83 patients in the statistical analysis: demographic param-
eters, NISS, blood sample times and mechanism of injury 
Table 1  Demographic parameters, NISS, blood sample times and mechanism of injury
Data are presented as No. of patients (No. pts) and percentage or as mean ± SD and range (minimum and maximum)
M male, F female, NISS new injury severity score
No. of patients 83
M/F 61 (73.5%)/22 (26.5%)
Age (years) 54 ± 19; 18–93
NISS 36 ± 13; 16–75
Time of first blood sample (T0) (min) 22 ± 7; 9–52
Time of second blood sample (T1) (min) 55 ± 19; 23–127




Run over by car/motorcycle 4 (4.8)
Crush 2 (2.4)
Fall from high 19 (22.9)
Other 9 (10.9)
Table 2  Vital parameters 
(mean ± SD) and patients with 
hypoperfusion indices (No. of 
patients and percentage) at T0 
and T1
p values < 0.05 are in bold
sAP systolic arterial pressure, HR heart rate, T temperature, SpO2 peripheral oxygen saturation, StO2 tissue 
oxygen saturation, BE base excess
T0 T1 p value
sAP (mmHg) 121 ± 36 125 ± 27 0.45
HR (bpm) 91 ± 25 89 ± 19 0.29
T (°C) 36 ± 1.7 36 ± 1.6 0.06
SpO2 (%) 94 ± 6 98 ± 3 0.001
StO2 (%) 79 ± 10 82 ± 9 0.003
No. pts with sAP < 90 mmHg 14 (16.9%) 5 (6%) 0.028
No. pts with BE ≤ − 6 mmol L−1 13 (15.7%) 16 (19.3%) 0.53
No. pts with  StO2 < 75% 16 (19.3%) 7 (8.4%) 0.04
No. pts with sAP < 90 mmHg + StO2 < 75% 3 (3.6%) 0 –
Table 3  Laboratory parameters and coagulation parameters 
(mean ± SD) at T0 and T1
p values < 0.05 are in bold
Hb blood hemoglobin, Hct hematocrit, PLT blood platelets, BE base 
excess, PTr prothrombin time ratio, PTTr partial thromboplastin time 
ratio, INR international normalized ratio
T0 T1 p value
Hb (g dL−1) 12.6 ± 2.2 12.1 ± 2.3 0.0001
Hct (%) 39.3 ± 7.2 37.7 ± 7.6 0.001
PLT (× 103 µL−1) 217 ± 92 212 ± 89 0.65
BE (mmol  L−1) − 3.3 ± 3.9 − 3 ± 4.1 0.41
PTr 1.52 ± 2.15 1.53 ± 1.9 0.72
PTTr 1.03 ± 0.62 1.04 ± 0.59 0.78
INR 1.43 ± 1.75 1.44 ± 1.56 0.69
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are shown in Table 1. Vital and laboratory parameters are 
reported in Tables 2 and 3.
TIC was found in 7 (9.7%) patients at T0 and in 9 
(11.2%) patients at T1. Blood mean FBN levels resulted in 
207 ± 66 mg dL−1 at T0 and 193 ± 72 mg  dL−1 at T1. Blood 
fibrinogen had a statistically significant change from T0 to 
T1 (p = 0.02), but it was not detected as a statistically sig-
nificant trend.
Hypoperfusion indices are shown in Table 2. The aver-
age amounts of fluids were: 779 ± 424 mL of crystalloids 
and 759 ± 365 mL of colloids; crystalloids and colloids were 
administered to 68 (81.9%) and 17 (20.5%) patients, respec-
tively. A hypertonic solution, from 100 to 250 mL, was given 
to 8 (9.6%) patients. Blood products were administered in 
35 (42.2%) patients within first 24 h after hospital admis-
sion: red blood cells (RBCs) were given in 31 (37.3%), fresh 
frozen plasma (FFP) in 16 (19.3%) and platelets in 4 (4.8%) 
patients. Twenty patients (24%) received tranexamic acid 
with no predefined criteria. The vital and laboratory param-
eters of this group showed no differences from patients who 
did not receive tranexamic acid.
Average TEG values at T0 and T1 are reported in Table 4. 
Stratification based on NISS showed no difference in TEG 
parameters between T0 and T1, except for statistically sig-
nificant R value in both groups NISS 25–40 and NISS > 40 
(p = 0.04 and p = 0.02, respectively). No correlation between 
TEG parameters and hypoperfusion parameters (sAP, BE, 
and  StO2) or temperature was found. In the tranexamic acid 
group, TEG parameters were similar to others.
Nine patients had normal TEG pattern on the trauma 
scene, three of them maintained normal TEG while remain-
ing 6 patients underwent different changes: 4 (5%) patients 
developed shortening of R, 1 (1.25%) showed hyperfibrinol-
ysis, and 1 (1.25%) developed hypercoagulation (Fig. 1). 
Three (3.75%) pathological TEG turned to normal at T1. 
Among them, 2 (2.5%) patients showed isolated shortening 
of R, and 1 (1.25%) had hypercoagulation at T0.
The distribution of TEG features is summarized in Fig. 1 
(three patients were lost for the coagulation analysis because 
TEG parameters were absent at T0 or T1). No difference in 
the prevalence of hypercoagulation and R < 9 patterns at 
T0 and T1 between NISS groups was detected. Within the 
same NISS group, there were no differences in the preva-
lence of hypercoagulation and R < 9 patterns between T0 
and T1. In patients who received tranexamic acid, no differ-
ence in the prevalence of hyper or hypocoagulation patterns 
was detected compared to the patients that did not receive 
tranexamic acid.
About changes in TEG features from T0 to T1: 17 TEG 
worsened, mostly (8 patients, 10%) becoming hypercoagu-
lant from an isolated shortening of R, while 19 improved, 
mainly (12 patients, 15%) acquiring isolated shortening of 
R from several patterns (hyper, hypocoagulation or hyperfi-
brinolysis). Forty-four patients had no changes in TEG fea-
tures, maintaining chiefly activation of coagulation (R < 9 
in 23, 28.7%, and hypercoagulation in 15, 18.8%, patients). 
(Table S1 on Supplemental Material).
Among patients with TIC, 3 had a normal TEG, 3 had 
hypercoagulation, and one had isolated shortening of R at 
T0. While at T1, 3 patients had normal TEG, 2 had hyperco-
agulation, 2 had hypocoagulation, and 2 had isolated short-
enings of R.
We divided our study population according to changes 
in the TEG pattern (worsened vs. not worsened). Search-
ing for the different prevalence of hypoperfusion param-
eters on the scene and at hospital admission (Table 5), only 
 StO2 < 75% at T0 showed a statistically significant difference 
in its prevalence in two groups (p = 0.02). No difference was 
found between the groups for the amount of fluid adminis-
trated. Worsened TEG group showed a mean temperature of 
35.2 ± 3 °C, while the other group had 36.2 ± 0.7 °C, with no 
statistically significant difference between T0 and T1.
Discussion
Early alteration of coagulation and hyperfibrinolysis
In our study, we found almost all (88.8%) trauma patients 
had a pathologic TEG already on trauma scene. The most 
represented pathological TEG patterns were shortening of 
R or hypercoagulation. These findings suggest that strong 
activation of the hemostatic system occurs within 30 min 
from trauma, and is maintained at hospital arrival.
Kaufmann et al. found that at hospital admission, the 
most represented hemostatic feature in an adult trauma pop-
ulation was hypercoagulation (included isolated shortening 
of R) [19]. Other TEG-versus-ROTEM comparison studies 
described a reduction in mean R value on early post-hospital 
admission TEG as well [20, 21].
In single TEG parameters analysis, the only R mean value 
showed a significant difference between on-scene and hos-
pital arrival: in a large majority of patients was detected an 
R value decreasing.
Table 4  TEG values at T0 and T1 (mean ± SD)
R R-time, k K value, Angle alpha angle, MA maximum amplitude
T0 T1 p value
R (min) 7.54 ± 3.5 5.8 ± 3.1 0.10
k (min) 3.51 ± 3.6 2.87 ± 3.7 0.59
Angle (grades) 54.39 ± 14.1 60.38 ± 10.4 0.10
MA (mm) 57.87 ± 8.5 58.97 ± 10.4 0.50
G (dyne/s) 7.09 ± 2.3 7.71 ± 2.3 0.41
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Only another study searched for early post-traumatic 
coagulation abnormalities with TEG. This study was 
similar to ours, but our population presented more severe 
injuries [17]. The authors found no differences in TEG 
values between on-scene and hospital admission, except 
for a slight increase in MA, whose mean value remains 
in a normal range. In this study, R mean value at hospital 
admission was at the lower limit of the normal range. This 
finding could be due to a smaller magnitude of trauma, so 
the activation of coagulation was still setting up.
Almost one-fourth of patients had a worsening in TEG 
pattern from “on the scene” to hospital arrival. Despite 
this finding, there was no significant difference in standard 
coagulation parameters between the on-scene and hospital 
admission setting. This observation could be due to the 
time frame we chose for analysis. In our data, a worsening 
in TEG was mostly represented by a hypercoagulation 
pattern.
Gonzalez et al. suggested that R value could be analogous 
to PT and PTT. These latter values represent the activation 
of coagulation factors, even if they are not interchangeable 
to each other [22]. In literature, R value showed a strong cor-
relation with PT and aPTT [23]. Despite significant changes 
in R values between the two groups which we had detected, 
we found no difference in variations of PT and PTT.
Very early after trauma, coagulation modifications 
are expected to be towards activation, so we aspected a 
shortening of R. Moreover, according to pathophysiology, 
changes in PT and PTT become substantial later in the 
clinical course of the traumatized patient. When coagu-
lation starts failing, a hypocoagulation pattern could be 
detected (which represents the alteration of coagulation for 
Fig. 1  Changes in pathological and normal TEG from T0 to T1. And TEG features at T0 and T1. Data are presented as No. of patients and per-
centage
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which these laboratory tests were specifically designed). 
Standard laboratory assays were developed to diagnose 
hypocoagulant conditions predominantly, so their applica-
tion in very early post-traumatic settings may hide the gain 
of a hypercoagulant profile.
Hyperfibrinolysis was found in a few patients (11.3%) 
on the scene, and its prevalence showed a slight decrease 
at hospital admission (8.8%). Our prevalence of hyperfi-
brinolysis at hospital admission is smaller than reported by 
the literature [24, 25] using the same Ly30 cut-off. It may be 
due to differences in trauma patients, who are mostly hemor-
rhagic, requiring massive transfusions protocol in Chapman 
et al. [24]. Moore et al. enrolled more patients than us, so it 
could maybe affect the sensitivity of detection. We did not 
find an increase in hyperfibrinolysis from the trauma scene 
to hospital admission. Trauma patients are at increased risk 
of developing shock-induced hyperfibrinolysis due to patho-
logical endothelial activation secondary to hypoperfusion 
and sympathoadrenal activation [26]. A few patients in our 
population presented more than two hypoperfusion markers 
on the trauma scene. The strategies to correct the hypoperfu-
sion in the pre-hospital environment could probably correct 
the coagulation factors.
A small number of patients in our population developed 
TIC: 9.7% on the scene and 11.2% at hospital admission. 
As there is not a unique definition of TIC, different preva-
lences are reported depending on the cut-off value used. In 
2003 Brohi et al. [4] published a large retrospective study, 
reporting that 24.4% of trauma patients had trauma acute 
coagulopathy (defined as PT > 18, aPTT > 60 s or TT > 15 s) 
at hospital admission. More recently, Davenport et al. found 
that 8% of trauma patients had PT ratio > 1.2. At the same 
time, Tauber et al. [16] and Hagemo et al. [15] using two 
different INR cut-off (1.5 and 1.2, respectively), found a 
coagulopathy in 14% and 11% of patients. In particular, 
Tauber et al. presented a population very similar to ours.
Patients with TIC did not exhibit a specific TEG pattern. 
They showed all possible kind of coagulation response to 
trauma: from normal to hyper- and hypocoagulant profile, 
to isolated shortening of R value. While prolonged INR and 
hypocoagulation move in the same direction, the finding of 
prolonged INR with normal or hypercoagulation pattern 
seems inconsistent. Standard laboratory tests detect the 
earliest initiation of clot formation [27], and PT/INR are 
extremely sensitive to clotting factors II, VII, and X [28]. 
Viscoelastic methods provide information about the whole 
coagulation process, exploring the interaction between all 
different components of the hemostatic system [29].
According to the cell-based paradigm of coagulation, TIC 
involved two critical players: platelets and endothelial cells. 
Immediately after trauma, the exposition of tissue factor 
from damaged tissues initiates coagulation through factor 
VII activation (the so-called “extrinsic pathway”). Factor 
VII is present in very low concentration in plasma and has 
the shortest half-life among all other coagulation factors 
[30]. Amplification and propagation are consequences of 
activation of endothelial cells, platelets, and other coagula-
tion factors [27], also from the so-called “intrinsic pathway” 
[31]. The concomitance of two conditions may explain a pro-
longed INR in the presence of a hypercoagulation pattern. 
The initiation of coagulation determines the consumption of 
circulating factors to which INR measurement is sensitive. 
The amplification and propagation of coagulation strengthen 
the clot, whose “strength” is represented only by VHAs.
Our study was not designed to search for a correlation 
between laboratory tests and VHA in the diagnosis of TIC. 
Table 5  Hypoperfusion parameters and fluid therapy (No.  of patients and percentage) between two groups based on TEG features (worsened vs. 
not worsened)
p values < 0.05 are in bold
Amounts of fluid administered are reported in brackets as mean ± SD
sAP systolic arterial pressure, BE base excess, StO2 tissue oxygen saturation
Worsened (n = 17) Not worsened 
(n = 63)
p value Worsened (n = 17) Not worsened 
(n = 63)
p value
Patients with T0 T1
sAP < 90 mmHg 4 (23.5) 8 (13.8) 0.33 2 (11.8) 2 (3.4) 0.18
sAP ≥ 90 mmHg 13 (76.5) 50 (86.2) 15 (88.2) 56 (96.5)
BE ≤ − 6 mmol L−1 2 (15.4) 10 (18.2) 0.8 4 (25) 10 (18.2) 0.54
BE ≥ − 6 mmol L−1 11 (84.6) 45 (81.8) 12 (75) 45 (81.8)
StO2 < 75% 7 (46.7) 8 (17.4) 0.02 1 (7.7) 5 (11.1) 0.72
StO2 ≥ 75% 8 (53.3) 38 (82.6) 12 (92.3) 40 (88.9)
Fluids Worsened p value
≥ 1000 mL (1454 ± 685) 6 (35.3) 0.72
< 1000 mL (478 ± 113) 11 (64.7)
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Despite this, our findings suggest that even if the on-going 
activation of coagulation, conventional coagulation tests 
could be normal during early blood loss [14]. Furthermore, 
standard laboratory tests may suggest normal coagulation in 
patients with hypercoagulation pattern at VHA.
On the other hand we have to notice that our results 
showed a little number of patients with INR > 1.5 and nor-
mal TEG (and thus normal R). This sounds like a surprising 
discrepancy between PT/INR and R time. In a recent study 
of Sumislawski, the authors found that 20% of patients with 
abnormal INR have normal ACT on rapid-TEG (which is 
a substitute of R time of TEG); moreover, the case studies 
of these authors were more severely injured and had lower 
activity levels for all coagulation factors (except for VIII) 
respect to patients with isolated abnormal ACT. Severity 
of injury and factor II level were identified by authors as 
independent predictors of discordance between conventional 
and viscoelastic test.[32]. However, there is not a still clear 
explanation of this discrepancy but, as Sumislawki suggests, 
it may reflect differences in coagulation factor activities and 
thus different clinical phenotypes.
TEG and NISS
The different coagulation patterns which we detected did not 
show any correlation with NISS value at any time. Regard-
less of when the determination is made, in the case of severe 
trauma, many patients show a hypercoagulation profile. No 
difference in R values from the scene to the hospital admis-
sion for NISS 15–24 was detected. In NISS 25–40 patients, 
a moderate difference was found; the difference was very 
significant for NISS > 40 patients. In other words, the devel-
opment of a hypercoagulation pattern is due to the severe 
trauma itself. More severe it is injury, greater is the magni-
tude of coagulation activation (R shortening).
TEG and hypoperfusion indices
Systolic arterial pressure and BE had not different distribu-
tion between patients whose TEG worsened and patients 
whose TEG remained stable or improved. At the same time, 
 StO2 < 75% was more present in the worsened TEG group. 
Thus, clinical features may not help to identify patients with 
ongoing post-traumatic hemostatic deranging early. There 
are a few studies that found a correlation between a hypop-
erfusion parameter such as BE, alone or with other clinical 
and laboratory features, and a single coagulation factor like 
blood fibrinogen [33, 34], but no one used VHA.
TEG and fluids
Hypercoagulation pattern at hospital admission was less 
represented in the group of patients who received more 
than 1000 mL of fluid for resuscitation than in the group of 
patients who received 1000 mL or less. No other TEG pat-
tern presented different distribution between the two groups 
depending on the amount of fluid administration. Fluid ther-
apy may have affected, through hemodilution, the real preva-
lence of hypercoagulant status at hospital admission. 10% of 
our patients presented hypocoagulation, hyperfibrinolysis, 
or a combination of the two patterns, on the scene. Fur-
thermore, despite a liberal fluid administration, at hospital 
admission, these patterns were less represented (6%).
The fluid administration could not be sufficient to cause 
a dilutional coagulopathy. Furthermore, hemodilution 
alone is known to be not enough to set up coagulopathy 
[27]. Post-traumatic coagulation changes are expected to be 
pro-coagulant, at least in the very first phase [35]. If hypop-
erfusion is not counteracted, hypocoagulation develops 
mediated by thrombomodulin via activated protein C [36], 
and, at last, hypercoagulation takes place again, leading to 
thrombotic complications [37]. In our population, the first 
samples were collected very early, so it is not surprising to 
find mostly hypercoagulation pattern. However, the second 
samples were collected in a time frame in which we could 
have expected a rising number of hypocoagulant profile. 
This second event did not take place because of blood loss, 
and resulting hypoperfusion was probably counteracted 
with the pre-hospital fluid administration. This manage-
ment could interrupt the pathway that would have led to 
hypocoagulation.
TEG and temperature
Most of our patients had only mild hypothermia on the 
scene, and at hospital admission as well. Mild hypothermia 
does not reduce enzyme activity [38, 39] and seems not to 
affect platelet activation. It could only cause platelet adhe-
sion defects [38]. Moreover, hypothermia plays a role in 
coagulation alteration later in the clinical course of trauma-
tized patients [36]. In our population, temperature alteration 
was too small to take part in early hemostatic derangement.
Limitations
During data collection, there were changes in fluid therapy 
from liberal to restrictive. Thus fluid administration in our 
population is not similar to the more recent literature on 
trauma. Furthermore, some patients received moderate 
volumes of colloids that are thought to impair coagula-
tion. Our study population had a wide distribution of age, 
NISS, mechanism, and type of injury. Injuries were mostly 
thoracic and cranial, and only one-third of patients needed 
a blood transfusion during the first 48 h after trauma. On 
average, patients maintained hemodynamic stability. They 
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also had a good balance of laboratory parameters such as 
hemoglobin, platelets, and base excess. No differences were 
observed between on-scene and hospital admission, accord-
ing to almost all hypoperfusion indices. Thus our population 
is not so representative of major bleeding trauma but more 
likely of a non-hemorrhagic subgroup of severe injury.
Conclusion
Our study shows that trauma-related alterations in coagula-
tion are early on the trauma scene. The shortening of R and 
a hypercoagulation profile are the most represented coagu-
lation alterations. Hyperfibrinolysis is found in a low per-
centage of patients, probably due to the non-hemorrhagic 
nature of our trauma population. Pro-coagulant changes 
develop very early after trauma, regardless of the severity 
of the injury. Damage severity appears to affect only the 
R parameter on TEG determination. Hypoperfusion param-
eters do not help to identify patients with ongoing coagula-
tion impairment. In non-hemorrhagic severe trauma patients, 
small volume resuscitation does not affect changes in the 
coagulation pattern at VHA. Mild hypothermia does not 
affect coagulation, at least in the early post-traumatic phase.
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